Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users' changing bodies – ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...

Eating a diet high in phytosterols, found in many plant foods, can reduce the risk of heart disease by 9% and type 2 diabetes ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

For patients with diabetes, exposure to GLP-1 RAs is associated with an increased risk for incident neovascular AMD development.

Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...

Andrew Stewart, MD, director, Mount Sinai Diabetes, Obesity, and Metabolism Institute, New York Now, we know that part of the problem also lies with your beta cells. These are the cells in your ...

Food scientists at the University of Illinois Urbana-Champaign identified the optimal fermentation conditions for pulses ― the dried edible seeds of legumes ― that increased their antioxidant and ...